Skip to main content

Advertisement

Log in

Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Mucin-producing intraductal papillary neoplasm (adenocarcinoma/adenoma) in the bile duct is becoming recognized as a specific type of neoplasm. Since, it bears a striking similarity to intraductal papillary mucinous neoplasms of the pancreas with regard to its histopathologic features, the term “intraductal papillary mucinous neoplasms of the bile duct” (IPMN-B) is frequently used, although no definite terminology or definition has been decided by World Health Organization. This neoplasm lacks ovarian-like stroma and communicates with the bile ducts, unlike biliary mucinous cystic neoplasm (MCN). On the other hand, malignant IPMN-B is categorized as an intraductal-growth type of intrahepatic cholangiocarcinoma (ICC). In comparison to other types of ICC, such as the mass-forming type and periductal-infiltrating type that have poor resectability and an unfavorable prognosis, malignant IPMN-B can be resected and demonstrates a more favorable prognosis. Meanwhile, unlike biliary MCN that is usually confined in a closed cyst, IPMN-B can spread along the mucosal surface of the bile ducts, and it should be widely resected. Therefore, multimodality assessment is needed to ensure the correct diagnosis of IPMN-B. We herein review the imaging findings of IPMN-B with pathologic correlation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wittekind C, Fischer HP, Ponchon T (2000) Bile duct cystadenoma and cystadenocarcinoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, France, pp 182–183

  2. Zen Y, Fujii T, Itatsu K, et al. (2006) Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol 19:1243–1254

    Article  PubMed  Google Scholar 

  3. Akiyoshi T, Yamaguchi K, Chijiiwa K, et al. (2003) Cystadenocarcinoma of the liver without mesenchymal stroma: possible progression from a benign cystic lesion suspected by follow-up imagings. J Gastroenterol 38:588–592

    PubMed  Google Scholar 

  4. Li T, Ji Y, Zhi XT, et al. (2009) A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasms. Clin Gastroenterol Hepatol 7:586–593

    Article  PubMed  Google Scholar 

  5. Chen TC, Nakanuma Y, Zen Y, et al. (2001) Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34:651–658

    Article  PubMed  CAS  Google Scholar 

  6. Lee SS, Kim MH, Lee SK, et al. (2004) Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 100:783–793

    Article  PubMed  Google Scholar 

  7. Ko SF, Chen YS, Ng SH, et al. (1996) Mucin-hypersecreting papillary cholangiocarcinoma presenting as abdominal wall abscess: CT and spiral CT cholangiography. Abdom Imaging 21:222–225

    Article  PubMed  CAS  Google Scholar 

  8. Sakamoto E, Nimura Y, Hayakawa N, et al. (1997) Clinicopathological studies of mucin-producing cholangiocarcinoma. J Hepato-Biliary-Pancreat Surg 4:157–162

    Article  Google Scholar 

  9. Kim H, Kim M, Lee S, et al. (2000) Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy 32:389–393

    Article  PubMed  CAS  Google Scholar 

  10. Shibahara H, Tamada S, Goto M, et al. (2004) Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28:327–338

    Article  PubMed  Google Scholar 

  11. Kloppel GKosmahl M (2006) Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol 44:249–250

    Article  Google Scholar 

  12. Zen Y, Sasaki M, Fujii T, et al. (2006) Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct–an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 44:350–358

    Article  PubMed  CAS  Google Scholar 

  13. Paik KY, Heo JS, Choi SH, et al. (2008) Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases. J Surg Oncol 97:508–512

    Article  PubMed  Google Scholar 

  14. Yeh TS, Tseng JH, Chiu CT, et al. (2006) Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg 244:248–253

    Article  PubMed  Google Scholar 

  15. Suzuki A, Suzuki S, Sakaguchi T, et al. (2008) A case of mucin-producing cholangiocarcinoma arising from the right hepatic duct. Jpn J Gastroenterol Surg 41:206–211

    Google Scholar 

  16. Isaji S, Kawarada Y, Taoka H, et al. (1999) Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:108–116

    Article  PubMed  CAS  Google Scholar 

  17. Suh KS, Roh HR, Koh YT, et al. (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31:12–17

    Article  PubMed  CAS  Google Scholar 

  18. Chen MF, Jan YY, Chen TC (1998) Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg 227:63–69

    Article  PubMed  CAS  Google Scholar 

  19. Kokubo T, Itai Y, Ohtomo K, et al. (1988) Mucin-hypersecreting intrahepatic biliary neoplasms. Radiology 168:609–614

    PubMed  CAS  Google Scholar 

  20. Lim JH, Ko YT, Lee DH, et al. (1990) Oriental cholangiohepatitis: sonographic findings in 48 cases. AJR Am J Roentgenol 155:511–514

    PubMed  CAS  Google Scholar 

  21. Lim J, Yi C, Lim H, et al. (2002) Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol 3:57–63

    Article  PubMed  Google Scholar 

  22. Holtkamp WReis HE (1994) Papillomatosis of the bile ducts: papilloma–carcinoma sequence. Am J Gastroenterol 89:2253–2255

    Google Scholar 

  23. Kim YS, Myung SJ, Kim SY, et al. (1998) Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy 30:763–767

    Article  PubMed  CAS  Google Scholar 

  24. Lee JW, Han JK, Kim TK, et al. (2000) CT features of intraductal intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 175:721–725

    PubMed  CAS  Google Scholar 

  25. Higashi M, Yonezawa S, Ho JJ, et al. (1999) Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 30:1347–1355

    Article  PubMed  CAS  Google Scholar 

  26. Nakanuma Y, Sasaki M, Ishikawa A, et al. (2002) Biliary papillary neoplasm of the liver. Histol Histopathol 17:851–861

    PubMed  CAS  Google Scholar 

  27. Chow L, Ahuja A, Kwong K, et al. (1997) Mucinous cholangiocarcinoma: an unusual complication of hepatolithiasis and recurrent pyogenic cholangitis. Histopathology 30:491–494

    Article  PubMed  CAS  Google Scholar 

  28. Zen Y, Fujii T, Itatsu K, et al. (2006) Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44:1333–1343

    Article  PubMed  CAS  Google Scholar 

  29. Osako M, Yonezawa S, Siddiki B, et al. (1993) Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 71:2191–2199

    Article  PubMed  CAS  Google Scholar 

  30. Sadler T (1988) Langman’s medical embryology. Plast Reconstr Surg 81:131

    Google Scholar 

  31. Furukawa T, Takahashi T, Kobari M, et al. (1992) The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer 70:1505–1513

    Article  PubMed  CAS  Google Scholar 

  32. Longnecker D, Adler G, Hruban R, et al. (2000) Intraductal papillary-mucinous neoplasms of the pancreas. WHO Classification of Tumors of the Digestive System, pp 237–240

  33. Tanaka M, Chari S, Adsay V, et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32

    Article  PubMed  Google Scholar 

  34. Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827

    PubMed  Google Scholar 

  35. Lim JH, Yoon KH, Kim SH, et al. (2004) Intraductal papillary mucinous tumor of the bile ducts. Radiographics 24:53–66 (discussion 66–57)

    Article  PubMed  Google Scholar 

  36. Lim JH, Jang KT, Choi D (2008) Biliary intraductal papillary-mucinous neoplasm manifesting only as dilatation of the hepatic lobar or segmental bile ducts: imaging features in six patients. AJR Am J Roentgenol 191:778–782

    Article  PubMed  Google Scholar 

  37. Kim YJ, Yun M, Lee WJ, et al. (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467–1472

    Article  PubMed  Google Scholar 

  38. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277–1285

    Article  PubMed  CAS  Google Scholar 

  39. Moon CM, Bang S, Chung JB, et al. (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23:759–765

    Article  PubMed  Google Scholar 

  40. Takanami K, Hiraide T, Kaneta T, et al. (2010) FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts. Clin Nucl Med 35:83–85

    Article  PubMed  Google Scholar 

  41. Bollow M, Taupitz M, Hamm B, et al. (1997) Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 7:126–132

    Article  PubMed  CAS  Google Scholar 

  42. Cruite I, Schroeder M, Merkle EM, et al. (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195:29–41

    Article  PubMed  Google Scholar 

  43. Stockberger SM, Sherman S, Kopecky KK (1996) Helical CT cholangiography. Abdom Imaging 21:98–104

    Article  PubMed  CAS  Google Scholar 

  44. Rigo P, Paulus P, Kaschten BJ, et al. (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641–1674

    Article  PubMed  CAS  Google Scholar 

  45. Anderson C, Rice M, Pinson C, et al. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90–97

    Article  PubMed  Google Scholar 

  46. Kim Y, Yun M, Lee W, et al. (2003) Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467–1472

    Article  PubMed  Google Scholar 

  47. Moon C, Bang S, Chung J, et al. (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23:759–765

    Article  PubMed  Google Scholar 

  48. Fritscher-Ravens A, Bohuslavizki K, Broering D, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277

    Article  PubMed  CAS  Google Scholar 

  49. Sperti C, Bissoli S, Pasquali C, et al. (2007) 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 246:932

    Article  PubMed  Google Scholar 

  50. Van Beers BE (2008) Diagnosis of cholangiocarcinoma. HPB (Oxford) 10:87–93

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kentaro Takanami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takanami, K., Yamada, T., Tsuda, M. et al. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36, 447–456 (2011). https://doi.org/10.1007/s00261-010-9649-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-010-9649-x

Keywords

Navigation